Genetic predisposition to ductal carcinoma in situ of the breast

Autor: Petridis, C., Brook, M.N., Shah, V., Kohut, K., Gorman, P., Caneppele, M., Levi, D., Papouli, E., Orr, N., Cox, A., Cross, S.S., dos-Santos-Silva, I., Peto, J., Swerdlow, A., Schoemaker, M.J., Bolla, M.K., Wang, Q., Dennis, J., Michailidou, K., Benitez, J., Gonzalez-Neira, A., Tessier, D.C., Vincent, D., Li, J.M., Figueroa, J., Kristensen, V., Borresen-Dale, A.L., Soucy, P., Simard, J., Milne, R.L., Giles, G.G., Margolin, S., Lindblom, A., Bruning, T., Brauch, H., Southey, M.C., Hopper, J.L., Dork, T., Bogdanova, N.V., Kabisch, M., Hamann, U., Schmutzler, R.K., Meindl, A., Brenner, H., Arndt, V., Winqvist, R., Pylkas, K., Fasching, P.A., Beckmann, M.W., Lubinski, J., Jakubowska, A., Mulligan, A.M., Andrulis, I.L., Tollenaar, R.A.E.M., Devilee, P., Marchand, L. le, Haiman, C.A., Mannermaa, A., Kosma, V.M., Radice, P., Peterlongo, P., Marme, F., Burwinkel, B., Deurzen, C.H.M. van, Hollestelle, A., Miller, N., Kerin, M.J., Lambrechts, D., Floris, G., Wesseling, J., Flyger, H., Bojesen, S.E., Yao, S., Ambrosone, C.B., Chenevix-Trench, G., Truong, T., Guenel, P., Rudolph, A., Chang-Claude, J., Nevanlinna, H., Blomqvist, C., Czene, K., Brand, J.S., Olson, J.E., Couch, F.J., Dunning, A.M., Hall, P., Easton, D.F., Pharoah, P.D.P., Pinder, S.E., Schmidt, M.K., Tomlinson, I., Roylance, R., Garcia-Closas, M., Sawyer, E.J.

Publikováno v: Breast Cancer Research, 18
Breast Cancer Research : BCR
Breast Cancer Research, 18. BioMed Central Ltd.
Petridis, C, Brook, M N, Shah, V, Kohut, K, Gorman, P, Caneppele, M, Levi, D, Papouli, E, Orr, N, Cox, A, Cross, S S, Dos-Santos-Silva, I, Peto, J, Swerdlow, A, Schoemaker, M J, Bolla, M K, Wang, Q, Dennis, J, Michailidou, K, Benitez, J, González-Neira, A, Tessier, D C, Vincent, D, Li, J, Figueroa, J, Kristensen, V, Borresen-Dale, A-L, Soucy, P, Simard, J, Milne, R L, Giles, G G, Margolin, S, Lindblom, A, Brüning, T, Brauch, H, Southey, M C, Hopper, J L, Dörk, T, Bogdanova, N V, Kabisch, M, Hamann, U, Schmutzler, R K, Meindl, A, Brenner, H, Arndt, V, Winqvist, R, Pylkäs, K, Fasching, P A, Beckmann, M W, Lubinski, J, Jakubowska, A, Mulligan, A M, Andrulis, I L, Tollenaar, R A E M, Devilee, P, Le Marchand, L, Haiman, C A, Mannermaa, A, Kosma, V-M, Radice, P, Peterlongo, P, Marme, F, Burwinkel, B, van Deurzen, C H M, Hollestelle, A, Miller, N, Kerin, M J, Lambrechts, D, Floris, G, Wesseling, J, Flyger, H, Bojesen, S E, Yao, S, Ambrosone, C B, Chenevix-Trench, G, Truong, T, Guénel, P, Rudolph, A, Chang-Claude, J, Nevanlinna, H, Blomqvist, C, Czene, K, Brand, J S, Olson, J E, Couch, F J, Dunning, A M, Hall, P, Easton, D F, Pharoah, P D P, Pinder, S E, Schmidt, M K, Tomlinson, I, Roylance, R, García-Closas, M & Sawyer, E J 2016, ' Genetic predisposition to ductal carcinoma in situ of the breast ', Breast Cancer Research, vol. 18, no. 1, pp. 22 . https://doi.org/10.1186/s13058-016-0675-7

Background Ductal carcinoma in situ (DCIS) is a non-invasive form of breast cancer. It is often associated with invasive ductal carcinoma (IDC), and is considered to be a non-obligate precursor of IDC. It is not clear to what extent these two forms o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f6eea26df5b32fcbfc20fd3bc24e85d6
https://researchonline.lshtm.ac.uk/id/eprint/2531430/1/13058_2016_Article_675.pdf

Genetic Predisposition to In Situ and Invasive Lobular\ud Carcinoma of the Breast

Autor: Sawyer, E., Roylance, R., Petridis, C., Brook, M.N., Nowinski, S., Papouli, E., Fletcher, O., Pinder, S., Hanby, A., Kohut, K., Gorman, P., Caneppele, M., Peto, J., Silva, I.D.S., Johnson, N., Swann, R., Dwek, M., Perkins, K-A., Gillett, C., Houlston, R., Ross, G., De Ieso, P., Southey, M.C., Hopper, J.L., Provenzano, E., Apicella, C., Wesseling, J., Cornelissen, S., Keeman, R., Fasching, P.A., Jud, S.M., Ekici, A.B., Beckmann, M.W., Kerin, M.J., Marme, F., Schneeweiss, A., Sohn, C., Burwinkel, B., Guenel, P., Truong, T., Laurent-Puig, P., Kerbrat, P., Bojesen, S.E., Nordestgaard, B.G., Nielsen, S.F., Flyger, H., Milne, R.L., Perez, J.I.A., Menendez, P., Benitez, J., Brenner, H., Dieffenbach, A.K., Arndt, V., Stegmaier, C., Meindl, A., Lichtner, P., Schmutzler, R.K., Lochmann, M., Brauch, H., Fischer, H-P., Ko, Y-D., Nevanlinna, H., Muranen, T.A., Aittomaki, K., Blomqvist, C., Bogdanova, N.V., Dork, T., Lindblom, A., Margolin, S., Mannermaa, A., Kataja, V., Kosma, V-M., Hartikainen, J.M., Chenevix-Trench, G., Lambrechts, D., Weltens, C., Van Limbergen, E., Hatse, S., Chang-Claude, J., Rudolph, A., Seibold, P., Flesch-Janys, D., Radice, P., Peterlongo, P., Bonanni, B., Volorio, S., Giles, G.G., Severi, G., Baglietto, L., Mclean, C.A., Haiman, C.A., Henderson, B.E., Schumacher, F., Le Marchand, L., Simard, J., Goldberg, M.S., Labreche, F., Dumont, M., Kristensen, V., Winqvist, R., Pylkas, K., Jukkola-Vuorinen, A., Kauppila, S., Andrulis, I.L., Knight, J.A., Glendon, G., Mulligan, A.M., Devillee, P., Tollenaar, R.A.E.M., Seynaeve, C.M., Kriege, M., Figueroa, J., Chanock, S.J., Sherman, M.E., Hooning, M.J., Hollestelle, A., van den Ouweland, A.M.W., van Deurzen, C.H.M., Li, J., Czene, K., Humphreys, K., Cox, A., Cross, S.S., Reed, M.W.R., Shah, M., Jakubowska, A., Lubinski, J., Jaworska-Bieniek, K., Durda, K., Swerdlow, A., Ashworth, A., Orr, N., Schoemaker, M., Couch, F.J., Hallberg, E., Gonzalez-Neira, A., Pita, G., Alonso, M.R., Tessier, D.C., Vincent, D., Bacot, F., Bolla, M.K., Wang, Q., Dennis, J., Michailidou, K., Dunning, A.M., Hall, P., Easton, D., Pharoah, P., Schmidt, M.K., Tomlinson, I., Garcia-Closas, M., Network, GENICA, Investigators, K

Invasive lobular breast cancer (ILC) accounts for 10–15% of all invasive breast carcinomas. It is generally ER positive (ER+) and\ud often associated with lobular carcinoma in situ (LCIS). Genome-wide association studies have identified more than 7

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::4ebe78e78d069ec27d7c747ccb1390cd

121 Risk Factors Associated with Lobular Carcinoma in Situ: Results of the GLACIER Study

Autor: Sawyer, E., Petridis, C., Kohut, K., Gorman, P., Caneppele, M., Roylance, R.

Publikováno v: In European Journal of Cancer March 2012 48 Supplement 1:S75-S76

DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?

Autor: Timbres J; Breast Cancer Genetics, King's College London, London SE1 9RT, UK., Kohut K; St George's University Hospitals NHS Foundation Trust, Blackshaw Rd, London SW17 0QT, UK., Caneppele M; Excelya, 35 rue de Paris, 92100 Boulogne, France., Troy M; Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London SE1 9RT, UK., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.; Department of Clinical Genetics, Leiden University Medical Centre, 2333 ZA Leiden, The Netherlands., Roylance R; University College London Hospitals NHS Foundation Trust, 235 Euston Rd., London NW1 2BU, UK., Sawyer E; Breast Cancer Genetics, King's College London, London SE1 9RT, UK.

Publikováno v: Cancers [Cancers (Basel)] 2023 Sep 02; Vol. 15 (17). Date of Electronic Publication: 2023 Sep 02.

Genetic predisposition to in situ and invasive lobular carcinoma of the breast.

Autor: Sawyer E; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom., Roylance R; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Petridis C; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom., Brook MN; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom., Nowinski S; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom., Papouli E; Biomedical Research Centre, King's College London, Guy's Hospital, London, United Kingdom., Fletcher O; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Pinder S; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom., Hanby A; Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, United Kingdom., Kohut K; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Gorman P; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Caneppele M; Centre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Peto J; London School of Hygiene and Tropical Medicine, London, United Kingdom., Dos Santos Silva I; London School of Hygiene and Tropical Medicine, London, United Kingdom., Johnson N; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom., Swann R; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom., Dwek M; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom., Perkins KA; Department of Molecular and Applied Biosciences, University of Westminster, London, United Kingdom., Gillett C; Research Oncology, Division of Cancer Studies, Kings College London, Guy's Hospital, London, United Kingdom., Houlston R; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom., Ross G; The Royal Marsden NHS Foundation Trust, London, United Kingdom., De Ieso P; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Southey MC; Department of Pathology, The University of Melbourne, Melbourne, Australia., Hopper JL; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia., Provenzano E; NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, United Kingdom., Apicella C; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia., Wesseling J; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Cornelissen S; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Keeman R; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Fasching PA; David Geffen School of Medicine, Department of Medicine Division of Hematology and Oncology, University of California at Los Angeles, Los Angeles, California, United States of America; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Jud SM; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Ekici AB; Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Beckmann MW; Department of Gynecology and Obstetrics, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Kerin MJ; Surgery, Clinical Science Institute, National University of Ireland, Galway, Ireland., Marme F; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany., Schneeweiss A; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; National Center for Tumor Diseases, University of Heidelberg, Heidelberg, Germany., Sohn C; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany., Burwinkel B; Department of Obstetrics and Gynecology, University of Heidelberg, Heidelberg, Germany; Molecular Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg, Germany., Guénel P; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France., Truong T; Inserm (National Institute of Health and Medical Research), CESP (Center for Research in Epidemiology and Population Health), U1018, Environmental Epidemiology of Cancer, Villejuif, France; University Paris-Sud, UMRS 1018, Villejuif, France., Laurent-Puig P; Université Paris Sorbonne Cité, UMR-S775 Inserm, Paris, France., Kerbrat P; Centre Eugène Marquis, Department of Medical Oncology, Rennes, France., Bojesen SE; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark., Nordestgaard BG; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark., Nielsen SF; Copenhagen General Population Study and Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark., Flyger H; Department of Breast Surgery, Herlev Hospital, Copenhagen University Hospital, Copenhagen, Denmark., Milne RL; Genetic & Molecular Epidemiology Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain., Perez JI; Servicio de Cirugía General y Especialidades, Hospital Monte Naranco, Oviedo, Spain., Menéndez P; Servicio de Anatomía Patológica, Hospital Monte Naranco, Oviedo, Spain., Benitez J; Human Genetics Group, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain., Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., Dieffenbach AK; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., Arndt V; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany., Stegmaier C; Saarland Cancer Registry, Saarbrücken, Germany., Meindl A; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany., Lichtner P; Institute of Human Genetics, Technische Universität, Munich, Germany., Schmutzler RK; Centre for Familial Breast and Ovarian Cancer and Centre for Integrated Oncology, University Hospital Cologne, Cologne, Germany., Lochmann M; Division of Gynaecology and Obstetrics, Technische Universität München, Munich, Germany., Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany; University of Tübingen, Tübingen, Germany., Fischer HP; Institute of Pathology, Medical Faculty of the University of Bonn, Bonn, Germany., Ko YD; Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany., Nevanlinna H; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Muranen TA; Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Central Hospital, Helsinki, Finland., Aittomäki K; Department of Clinical Genetics, Helsinki University Central Hospital, Helsinki, Finland., Blomqvist C; Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland., Bogdanova NV; Department of Radiation Oncology, Hannover Medical School, Hannover, Germany., Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany., Lindblom A; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Margolin S; Department of Oncology - Pathology, Karolinska Institutet, Stockholm, Sweden., Mannermaa A; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland., Kataja V; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland., Kosma VM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland., Hartikainen JM; School of Medicine, Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Joensuu, Finland; Cancer Center, Kuopio University Hospital, Kuopio, Finland., Chenevix-Trench G; Department of Genetics, QIMR Berghofer Institute of Medical Research, Brisbane, Australia., Lambrechts D; Vesalius Research Center (VRC), VIB, Leuven, Belgium; Department of Oncology, University of Leuven, Leuven, Belgium., Weltens C; University Hospital Gashuisberg, Leuven, Belgium., Van Limbergen E; University Hospital Gashuisberg, Leuven, Belgium., Hatse S; University Hospital Gashuisberg, Leuven, Belgium., Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Rudolph A; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Seibold P; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Flesch-Janys D; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Radice P; Unit of Molecular Bases of Genetic Risk and Genetic Testing, Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy., Peterlongo P; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy., Bonanni B; Division of Cancer Prevention and Genetics, Istituto Europeo di Oncologia (IEO), Milan, Italy., Volorio S; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare and Cogentech Cancer Genetic Test Laboratory, Milan, Italy., Giles GG; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia., Severi G; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia., Baglietto L; Cancer Epidemiology Centre, The Cancer Council Victoria, Melbourne, Australia; Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, Australia., McLean CA; Department of Pathology, The Alfred Hospital, Prahran, Victoria, Australia., Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Henderson BE; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Schumacher F; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America., Le Marchand L; Epidemiology Program, Cancer Research Center, University of Hawaii, Honolulu, Hawaii, United States of America., Simard J; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada., Goldberg MS; Department of Medicine, McGill University, Montreal, Quebec, Canada; Division of Clinical Epidemiology, McGill University Health Centre, Royal Victoria Hospital, Montreal, Quebec, Canada., Labrèche F; Département de médecine sociale et préventive, Département de santé environnementale et santé au travail, Université de Montréal, Montreal, Quebec, Canada., Dumont M; Cancer Genomics Laboratory, Centre Hospitalier Universitaire de Québec Research Center and Laval University, Quebec, Canada., Kristensen V; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway; Faculty of Medicine (Faculty Division Ahus), UiO, Oslo, Norway., Winqvist R; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab/Oulu University Hospital, Oulu, Finland., Pylkäs K; Laboratory of Cancer Genetics and Tumor Biology, Department of Clinical Chemistry and Biocenter Oulu, University of Oulu, NordLab/Oulu University Hospital, Oulu, Finland., Jukkola-Vuorinen A; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland., Kauppila S; Department of Oncology, Oulu University Hospital, University of Oulu, Oulu, Finland., Andrulis IL; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada., Knight JA; Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada; Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada., Glendon G; Ontario Cancer Genetics Network, Fred A. Litwin Center for Cancer Genetics, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ontario, Canada., Mulligan AM; Laboratory Medicine Program, University Health Network, Toronto, Ontario; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada., Devillee P; Department of Human Genetics & Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Tollenaar RA; Department of Surgical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Seynaeve CM; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands., Kriege M; Family Cancer Clinic, Department of Medical Oncology, Erasmus MC-Daniel den Hoed Cancer Center, Rotterdam, The Netherlands., Figueroa J; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America., Chanock SJ; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America., Sherman ME; Division of Cancer Prevention, National Cancer Institute, Bethesda, Maryland, United States of America., Hooning MJ; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hollestelle A; Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van den Ouweland AM; Department of Clinical Genetics, Erasmus University Medical Center, Rotterdam, The Netherlands., van Deurzen CH; Department of Pathology, Erasmus University Medical Center, Rotterdam, The Netherlands., Li J; Human Genetics Division, Genome Institute of Singapore, Singapore., Czene K; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Humphreys K; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Cox A; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom., Cross SS; Academic Unit of Pathology, Department of Neuroscience, University of Sheffield, Sheffield, United Kingdom., Reed MW; CRUK/YCR Sheffield Cancer Research Centre, Department of Oncology, University of Sheffield, Sheffield, United Kingdom., Shah M; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Jakubowska A; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Lubinski J; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Jaworska-Bieniek K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland; Postgraduate School of Molecular Medicine, Warsaw Medical University, Warsaw, Poland., Durda K; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Swerdlow A; Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, Sutton, Surrey, United Kingdom., Ashworth A; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom., Orr N; Breakthrough Breast Cancer Research Centre, Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom., Schoemaker M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, United States of America., Hallberg E; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, United States of America., González-Neira A; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain., Pita G; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain., Alonso MR; Human Genotyping-CEGEN Unit, Human Cancer Genetics Program, Spanish National Cancer Research Centre [CNIO], Madrid, Spain., Tessier DC; McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada., Vincent D; McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada., Bacot F; McGill University and Génome Québec Innovation Centre, Montréal, Québec, Canada., Bolla MK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Dennis J; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Michailidou K; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Dunning AM; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom., Hall P; Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Easton D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Pharoah P; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom., Schmidt MK; Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Tomlinson I; Wellcome Trust Centre for Human Genetics and Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom., Garcia-Closas M; Division of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom; Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom.

Publikováno v: PLoS genetics [PLoS Genet] 2014 Apr 17; Vol. 10 (4), pp. e1004285. Date of Electronic Publication: 2014 Apr 17 (Print Publication: 2014).